Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease
Theranostics · 2025
DOI: 10.7150/thno.105876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Rebiguli Aji und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School o…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Mesenchymal Stem Cells, Interleukin-10, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, Chi…
- School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China.
Zitieren
APA
Aji, R., Xu, Y., Wang, Z., Feng, W., Gui, L., Rao, H., Zhang, W., Liu, N., Gao, W. Q., & Li, L. (2025). Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease. Theranostics. https://doi.org/10.7150/thno.105876
Vancouver
Aji R, Xu Y, Wang Z, Feng W, Gui L, Rao H, et al. Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease. Theranostics. 2025. doi:10.7150/thno.105876
BibTeX
@article{Aji2025,
author = {Aji, Rebiguli and Xu, Yue and Wang, Ziyi and Feng, Wenxin and Gui, Liming and Rao, Hanyu and Zhang, Wei and Liu, Ningyuan and Gao, Wei-Qiang and Li, Li},
title = {Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.105876}
}
EUVIMED